- Open Access
Inflammatory responses to dietary and surgical weight loss in male and female mice
Biology of Sex Differences volume 10, Article number: 16 (2019)
Weight loss by surgery or lifestyle changes is strongly recommended for obese individuals to improve metabolic health, but the underlying impairments that persist from a history of obesity remain unclear. Recent investigations demonstrate a persistent inflammatory state with weight loss and bariatric surgery, but the mechanism and impact are not fully understood. Additionally, these studies have not been performed in females although women are the majority of individuals undergoing weight loss interventions.
The goal of this study was to determine the sex differences in metabolically induced inflammation after dietary weight loss (WL) or bariatric surgery. Following a 60% high-fat diet (HFD) for 12 weeks, C57Bl/6j mice underwent either a dietary switch to normal chow for WL or vertical sleeve gastrectomy (VSG) and were evaluated 8 weeks after intervention. WL effects on myelopoiesis were further evaluated with bone marrow chimeras.
Both sexes had a decrease in adiposity and total weight following WL or VSG intervention. With HFD, females had very little inflammation and no further increase with WL, but males had persistent inflammation even after WL despite metabolic improvement. Interestingly, after VSG, myeloid inflammation was increased in the livers of males and to a lesser extent in females.
These studies demonstrate that regardless of sex, it is critical to assess an individuals’ history of obesity rather than just rely on current weight status in medical decision-making. There are long-lasting effects on tissue inflammation in both sexes especially with surgical weight loss. Dietary change is overall most effective to improve meta-inflammation in obese males on its own or in combination with surgical weight loss.
Obesity is a significant public health crisis due to the rise in predominantly metabolic sequelae [1,2,3]. Many weight loss interventions have been created to attenuate the medical sequelae of obesity. While there have been pharmacologic treatments , the most popular sought-after interventions include dietary/lifestyle changes and more recently bariatric surgery . Although a 10–20% reduction in weight can have significant metabolic improvements with improved glucose and insulin levels , effects on the chronic inflammatory state of obesity have been less thoroughly examined.
Following high-fat caloric intake, adipose tissue depots expand leading to obesity. Concurrent with this expansion is an increase of both resident and recruited tissue macrophages in response to adipocyte hypertrophy . An increase in chemokine signals within gonadal white adipose tissue (GWAT), the main visceral fat depot in animal models, leads to expansion of recruited macrophages. Specifically, monocyte chemoattractant protein-1/C-C chemokine receptor type 2 (MCP-1/CCR2) signals are known to recruit Ly6chi monocytes, which differentiate into CD64+/CD11c+ adipose tissue macrophages (CD11c+ ATMs)  and accumulate in crown-like structures (CLS), around damaged and dying adipocytes . CD11c+ ATMs are linked to obesity-related sequelae and are functionally distinct from resident, CD64+CD11c− macrophages (CD11c− ATMs) . While these CD11c+ macrophages typically help with maintaining tissue homeostasis , the expansion and detrimental cytokine production leads to a pathologic state of tissue dysfunction.
Weight loss has become a primary recommendation for resolution of obesity and obesity-related diseases. However, recent investigations into the impact of weight loss in animal models have determined that even with weight loss, there is an underlying myeloid inflammation that remains for at least 8 weeks . Similar findings have been observed in studies using vertical sleeve gastrectomy, demonstrating a persistent inflammatory state post-weight loss [12, 13]. While these are clinically relevant pre-clinical findings, there is a critical gap in the inclusion of female animal models in these studies. This is an important gap to fill given that over 80% of bariatric surgeries [14, 15] and a majority of dietary and exercise weight loss programs are predominantly filled with women . Also, there is some controversy in the results since some studies have demonstrated improvement in systemic inflammation with dietary weight loss [17, 18] and some report no changes at all within adipose tissue [19, 20]. These contradictory results may be due to the age, timing of weight loss, and sex differences.
In order to understand if the persistent tissue inflammation and metabolic dysfunction is a critical issue in men and women after weight loss, we have pursued investigations in both male and female animal models. We hypothesized that given the priming of males to meta-inflammation, persistent inflammation would be most prominent in male mice than females with obesity and weight loss regardless of method. Our studies show that male animals had improved but some persistent adipose tissue and liver inflammation even after weight loss while female adipose tissue remained in a low-inflammatory state. The programming of this priming for tissue inflammation persisted after bone marrow transplantation (BMT) in male animals. Surprisingly, with vertical sleeve gastrectomy, adipose tissue inflammation due to resident CD11c− macrophages was sustained in both post-surgical males and females.
Animals and animal care
Male and female C57Bl/6J mice were purchased from Jackson Laboratory (Bar Harbor, Maine). Six-week-old male and female mice were fed either a normal diet (LabDiet 13.5% fat 5L0D, St. Louis, MO) or high-fat diet (HFD, Research Diets D12492 60% fat, New Brunswick, NJ). A subgroup of HFD-induced obese mice was switched back to ND after 12 weeks of HFD to create the weight loss (WL) animal model. About 4–8 mice were used for dietary experiments. Glucose tolerance tests (GTT) were performed after 6 h of fasting. Mice were injected with intraperitoneal insulin (0.7 g/kg) and D-glucose (Gibco, Indianapolis, IN) measured by Free-Style Lite glucose meter. All mouse procedures were approved by the University of Michigan Committee on Use and Care of Animals and were conducted in compliance with the Institute of Laboratory Animal Research Guide for the Care and Use of Laboratory Animals.
Vertical sleeve gastrectomy surgery
Animals were placed on 12 weeks of HFD starting at 6 weeks of age. Two weeks prior to surgery (after 10 weeks of HFD), mice were singly housed. Mice were then separated into two surgery groups, sham surgery or vertical sleeve gastrectomy (VSG). After surgery, animals from the sham group were either continued on 60% high-fat diet for 8 weeks or switched to control chow. All surgeries were performed under isoflurane anesthesia as previously described [12, 21]. For VSG, the lateral stomach was resected along the major curvature to form a remnant tube. A N of 4–8 again was used in sham groups but a larger N was used in the VSG groups for experiments (8–12) given complications that could occur in this group. Sham procedures involved exposure and manipulation of the stomach. After surgery, mice were fed a liquid diet Osmolite 1Cal (Abbott Nutrition, Columbus, OH) for 4 days, then switched into either ND or HFD for 8 weeks.
Whole-mount adipose tissue explants were fixed overnight in a 1% paraformaldehyde solution (Electron Microscopy Sciences, Hatfield, PA) and were used for immunofluorescence as previously described . Antibodies used for immunofluorescence included Caveolin1 (Polyclonal rabbit-anti-Caveolin, BD Pharmingen, San Jose, CA), Mac2 (Rat Galectin-3 monoclonal antibody (M3/38), BD Pharmingen, San Jose, CA), and 4′,6-Diamidine-2′-phenylindole dihydrochloride (DAPI) (Roche, Basel, Swiss). Secondary antibodies included goat anti-rabbit IgG Alexa Fluor 488 (polyclonal, Invitrogen, Carlsbad, CA) and goat anti-rat IgG Alexa Fluor 568 (polyclonal, Invitrogen, Carlsbad, CA).
Adipose tissue and liver were digested in RPMI 1640 (Gibco, Indianapolis, IN) with 1 mg/ml collagenase (Clostridiopeptidase A from Clostridium histolyticum type II Sigma-Aldrich, St. Louis, MO) as previously described  on a rocking platform shaker for 25 min at 37 °C. The stromal vascular fraction (SVF) was separated from adipocytes by centrifugation. The following antibodies were used for flow cytometry: anti-mouse CD45 eFluor 450 (30-F11 monoclonal, Invitrogen, Carlsbad, CA), anti-mouse CD11c eFluor 780 (N418 monoclonal, Invitrogen, Carlsbad, CA), anti-mouse CD64 PE (X54-5/7.1 monoclonal, BD Pharmingen, San Jose, CA), and anti-mouse Ly6G (Gr1) FITC (IA8, BD Pharmingen, San Jose, CA). Adipose tissue macrophages are CD64+ and separated as M2 (CD11c−) or M1 (CD11c+). Dendritic cells are CD64−CD11c+ cells. Analysis was performed using a BD Biosciences FACSAria and FlowJo v.10 (Treestar) software.
Results are presented as mean ± SEM. The analysis was first performed to evaluate for any significant main effects and interactions regarding sex and diet. Comparisons were then made with one-way ANOVA using Tukey’s method followed by a three-factor general linear model. Table 1 provides the results of general linear models assessing the significance of the main effects and interactions for the three factors: sex, surgery, and diet. Table 2 gives the results of Tukey’s multiple comparisons by providing adjusted p values.
Males have impaired metabolism with HFD that resolves in weight loss (WL), while females remain metabolically intact
Male and female C57Bl/6J mice were placed on ND or fed a 60% HFD starting at 6 weeks of age. After 12 weeks of HFD, one group of animals was switched back to a control chow to mimic dietary WL. After 8 weeks of normal chow, the body weights of the WL group reduced and were similar to the ND animal weights for both males and females (Fig. 1a, b). After 6 weeks of WL, all animals were fasted for 6 h and serum glucose and insulin evaluated. Fasting glucose levels varied by diet in both sexes and were significantly lower in WL females compared to males (p < 0.001 for diet and sex effects) (Fig. 1c). Male insulin levels were increased with HFD, as we have previously shown , but female insulin levels did not significantly increase with HFD and were significantly lower in HFD females (Fig. 1d). After just 6 weeks, the WL group had significantly lower insulin levels in male mice (Fig. 1d). At 19 weeks of HFD, glucose tolerance testing was impaired in males. However, with 7 weeks of diet switch, glucose tolerance improved in male WL animals compared to HFD (Fig. 1e). Female animals remained glucose tolerant in HFD and WL states (Fig. 1f).
As expected, HFD increased body mass and liver mass in males and weight loss reduced both body weight and liver weight to that of control animals, as previously published  (Fig. 1g, h). There was a significant sex effect with female HFD animals having lower weight and liver mass (Fig. 1g, h). HFD animals had increased visceral gonadal white adipose tissue (GWAT) and subcutaneous inguinal white adipose tissue (IWAT) depots in both sexes (Fig. 1i, j). After 8 weeks of diet switch, WL animals still had heavier GWAT fat pads while IWAT weights returned to control weights in both sexes (Fig. 1i, j).
Males have an increased myeloid response to HFD that persists in WL
To assess potential changes in the degree of inflammation after a WL intervention, we isolated targeted metabolic tissues and evaluated leukocytes by flow cytometry in the weight loss mice model. GWAT macrophages expanded in HFD males and did not fully resolve in WL mice (Fig. 2a). HFD-fed females had no expansion in GWAT macrophages, and these did not change with diet switch (Fig. 2a). In males, GWAT ATMs regardless of CD11c type were increased in HFD and WL, though weight loss did show inflammatory CD11c+ ATM reduction when compared to HFD animals (Fig. 2a). Dendritic cells (DCs) were similar amongst all groups in both sexes (Fig. 2a).
A similar pattern of expansion of ATMs was seen in male HFD IWAT, but DCs were also expanded and both myeloid populations reduced with WL (Fig. 2b). ATMs and DCs in subcutaneous inguinal fat did not significantly expand in HFD females and were unchanged with weight loss (Fig. 2b). Tissue macrophages increased within the liver in males on HFD (Fig. 2c). Within the liver, CD64+ cells increased only marginally in males with HFD but significantly so with WL and were mostly the CD11c− type. CD64−CD11c+ cells increased with HFD in both sexes and reduced with WL (Fig. 2c). Similar to the fat depots, WL resolved CD11c+CD64+ cell accumulation in male livers as well. The resolution in CD11c+ populations is critical given that this cell population is strongly associated with antigen presentation and T cell activation. Since CD11c+ ATMs are thought to be recruited, it is interesting that this macrophage population completely improved in IWAT and liver, but not in GWAT.
Consistent with our prior studies, myeloid granulocyte and macrophage precursors (GMPs) increased in males with HFD but more significantly so in WL [8, 24] (Fig. 2d). Overall, these results demonstrate that in males, myeloid inflammation is only partially improved with WL in visceral tissues but significantly improved in liver and IWAT.
Hematopoietic cells transplanted from WL animals are not primed to impair metabolism
To determine whether hematopoietic stem cell changes due to obesity or weight loss might contribute to varied inflammatory responses, we performed bone marrow transplant experiments. Twenty-six-week-old animals from ND, HFD, or WL groups were used as bone marrow donors. Bone marrow was isolated and injected into 8-week-old WT C57Bl/6J irradiated recipient animals. For these experiments, donor sex was the same as recipient sex. Animals were allowed to recover from bone marrow transplantation (BMT), and 6 weeks post-BMT were challenged to 16 weeks HFD to determine if a subsequent HFD challenge, second hit, to the bone marrow would lead to a priming for increased metabolic inflammation. In males, we have previously observed that with 16 weeks of HFD, bone marrow transplant and re-challenge leads to increased glucose impairment over ND recipient BMT animals . Consistent with prior results, males with HFD donor BM had impaired insulin sensitivity as seen in insulin tolerance test (ITT) (Fig. 3a) and glucose intolerance in males (Fig. 3b). While not significant, male animals with WL BM tended to have higher glucoses in response to insulin (ITT) (p = 0.07 ND vs WL).
In contrast, no changes were observed in female groups regardless of donor group (Fig. 3c). While there were differences in glucose homeostasis in males, there was no significant difference in body weight (Fig. 3d), GWAT (Fig. 3e), IWAT (Fig. 3f), or liver (Fig. 3g) by donor group. This suggests that the HFD donor BM impaired glucose homeostasis independent of body, fat pad, or liver mass. As expected, weights for all variables were lower in females than males (sex effect p < 0.001). We further isolated tissues to look at tissue macrophages and found that there was a near significant diet effect and animals with male HFD donor marrow had a larger number of ATMs in GWAT and IWAT (Fig. 4a, b) and more total ATMs than female mice (sex effect p < 0.001). There were no significant differences in GWAT or IWAT ATM type or DCs, although females still had lower numbers (Fig. 4a, b). A similar trend was observed in the liver with lower numbers of macrophages in females but no differences amongst diet groups (Fig. 4c). Overall, in female animals, marrow, regardless of prior exposure, remains protected from myeloid responsiveness to HFD.
VSG and WL both improve body composition of formerly HFD fed mice regardless of sex
To understand whether surgically induced weight loss responses differ from standard diet weight switch, animals were treated with 12 weeks of HFD and then underwent sham or VSG surgery. Post-surgery, sham animals were either maintained on HFD or switched to a standard chow, to mimic WL controls. VSG animals were standardly maintained on HFD to assess surgery weight loss effects alone. A small group of VSG animals was switched to standard chow after surgery to mimic our prior WL studies. Chow switch in sham and VSG animals led to improved weight loss compared to VSG alone (Fig. 5a), with greater improvement in fat mass loss (Fig. 5b, c) and reduction in adipocyte size changes (Fig. 5d, e). VSG itself without diet switch led to improved body weight and IWAT weight in males (Fig. 5a, c), with near significant improvement in GWAT weight in females (Fig. 5b). However, liver weight increased only in male HFD-fed animals and resolved in both VSG treatment groups or chow switch. No effects of liver weight were observed in either of the female groups (Fig. 5f). Overall, while VSG improved body weight, IWAT, and liver mass, there was an additive effect with chow switch. Interestingly, splenomegaly occurred in VSG groups of both sexes but significantly so only in male HFD groups (Fig. 5g).
VSG and WL both decrease obesity-associated adipose tissue CD11c+ ATMs in male mice
Flow cytometry analysis of visceral adipose tissue (VAT) macrophages showed that a chow switch reduced ATMs and to a greater extent than VSG in males and females (Fig. 6a). A switch to chow significantly decreased ATMs when comparing both subtypes (CD11c+ and CD11c−) (Fig. 6b, c), while VSG decreased mostly CD11c+ ATMs. DCs were also reduced but not significantly different with chow switch and VSG in male animals (Fig. 6d). VSG however increased neutrophils indicated by Ly6G+ cells in adipose tissue in both sexes with lack of significant two-factor interaction but significant surgery effect (p < 0.001) (Table 1 and Fig. 6e). The alteration in CD11c+ ATM accumulation was seen by persistent CLS in male animals in sham HFD, with some improvement with VSG (Fig. 6f). The CLSs appear more prominent in this group due to continued adipocyte hypertrophy in HFD-fed animals while adipocytes were small with the chow switch (Fig. 6f). Similar findings were observed in the IWAT compartment, with greater reduction in CD11c+ ATMs by chow switch in males only (Fig. 7a, b). Unlike the GWAT, CD11c− ATMs and DCs did not show any significant changes in the VSG HFD groups in male and female IWAT (Fig. 7c, d). To understand if the female protection from adipose inflammation was due to estrogen, a subgroup of ovariectomized mice underwent VSG and was found to have little change in ATM accumulation with no significant change in inflammation with VSG (Fig. 7e).
VSG resolves pro-inflammatory ATMs in males but promotes CD11c− TMs numbers in both sexes in liver
VSG is well known to relieve obesity-related hyperlipidemia and NAFLD . In addition to steatosis, liver inflammation and fibrosis is part of the pathology to steatohepatitis. Therefore, we next evaluated leukocytes within the liver. In males, HFD enhances CD64+ cells with some resolution with chow switch but not with VSG (Fig. 8a). While CD64+CD11c+ cells increased with HFD in males (as seen in Fig. 2c), they improved both with VSG and even more with chow switch. CD64+ CD11c− cells, however, increased with VSG (Fig. 8b, c). DCs were also expanded with HFD but improved with VSG and chow switch in males (Fig. 8d). Females failed to show any significant effects with VSG on liver macrophages (Fig. 8a–d). Imaging studies showed dense pockets of leukocytes suggesting extramedullary hematopoiesis in post-VSG animals (Fig. 8f) that corresponded with increased neutrophils by flow cytometry in both sexes as demonstrated by lack of significant two-factor interaction but significant surgery effect (p < 0.001) (Table 1 and Fig. 8e).
Our findings demonstrate that weight loss intervention strategies have a more profound effect in myeloid inflammatory reduction in males than females. This observation holds true for both dietary-related weight loss and VSG. It is worth noting that females are protected from obesity-induced myeloid inflammatory responses relative to males and overall have a decreased capacity to elicit a myeloid reduction. Nevertheless, our results suggest that both weight loss intervention strategies are more effective in reducing pro-inflammatory myeloid cell populations in males than females. However, both the strategies of dietary and surgical interventions to reduce obesity failed to completely resolve myeloid inflammation in male mice, although inflammation was lowered more with dietary intervention. This is crucial because it shows that dietary strategies should be considered in addition to surgical intervention alone, in males. It also suggests that some of the benefits attributed to surgery are dependent on an improved dietary intake after surgery. When utilized independently, both intervention strategies should be considered only semi-effective strategies in reducing myeloid cell populations in males, although metabolism is improved.
Surprisingly, there was a higher level of CD11c− ATMs with VSG in GWAT of both sexes although CD11c+ ATMs improved (Fig. 6). Ly6Ghi neutrophil populations were exacerbated by VSG and may likely be correlated with an increase in splenic mass and extramedullary hematopoiesis in both sexes (Fig. 5g). CD11c+ populations, which have been highly implicated in metabolic disease, are affected differentially by intervention strategy. It is possible that the type of weight loss has a significant difference in metabolic disease, with standard dietary weight loss improving myeloid inflammation compared to VSG/surgical weight loss due to the slower nature of weight loss with diet versus surgery. Also, all animals in the surgical groups with either sham or VSG surgery had generally lower weights and lower ATM content than just WL experiments. This could be due to recovery from a surgery or from expansion of another population of SVF cells (leukocytes or pre-adipocytes) that was not measured in these experiments.
Weight loss programs are primarily undertaken in women, but the impact on inflammation and metabolism is more significant in males since weight loss by both dietary and surgical interventions reduced metabolic impairment and inflammation more in males. Clinically, it has been found that males and females have different metabolic responses to low energy diet, with men having greater reductions in metabolic syndrome Z score, C-peptide, fat mass, and heart rate, while females had greater reductions in HDL cholesterol, blood pressure, and hip circumference . Animal studies have previously demonstrated that in males, weight loss specifically leads to improved metabolism; however, inflammation persists due to local macrophage proliferation . Mechanistically, this is thought to be due to enhanced lipolysis promoting proliferation of immune cells . Although female animals also have significant adiposity, improvements yet fail to generate inflammation with standard weight loss suggesting that there is a sex difference in response to this type of slow lipolysis. One possibility is that females have greater capability to store adipose tissue and therefore a lesser requirement to generate ATMs that are important for clearance of fatty acids and lipids. Also, female ATMs may have a greater potential for beta oxidation not requiring pro-inflammatory activation. Hence, a sex difference in weight loss mediated lipolytic response and lipid metabolism may contribute to sex differences in inflammation. Interestingly, recent studies performed in rats have shown a similar increased inflammatory phenotype in female livers post-VSG associated with worsened hepatic triglycerides . The findings of extramedullary hematopoiesis and likely myeloid progenitor increases even after weight loss and BMT are likely mechanisms causing such persistent inflammation in WL even in a clinical setting.
Unlike standard WL, during VSG, both sexes exhibit some splenomegaly and myeloid inflammation increases with neutrophils in the GWAT and myeloid cells in the liver. This suggests that with acute lipolysis, both sexes are primed to produce inflammation to respond to the rapid weight loss, but the response is greater in male animals. Previously, similar systemic inflammatory responses were demonstrated in male animals . While our finding in females is unexpected, it is a clinically relevant result since nearly 80% of bariatric surgery patients are females  and success in weight reduction and T2DM resolution has been observed 5 years after VSG in predominantly female cohorts . However, it is critical to continue to monitor risk for meta-inflammation and its cardiovascular and metabolic consequences in females .
Men have been shown to have increased morbidity and resource utilization post-bariatric surgery , and our findings of persistent inflammation in male mice may explain some of this result. One limitation of our study is the identification of the key factors that promote the systemic inflammatory response post-VSG. We did observe that these factors are related to the VSG surgery itself, and not related to a foreign body response, using a staple sham group (not shown). There are many possible lipid mediators, inflammatory mediators, and altered hormones that are likely be responsible, but given systemic hematopoiesis, it is possible that there are factors systemically released that drive myelopoiesis or that prompt the need for inflammatory leukocytes. Specifically, free fatty acids may directly stimulate ATM proliferation [27, 32]. However, this release from tissues was not specifically measured in these studies but many lipid mediators are known to trigger both ATM proliferation and hematopoiesis [32, 33]. Additionally, given that there is significant adipose remodeling and there are likely hematopoietic progenitors within adipose tissue, it may be this reservoir that remains activated in males even post-weight loss . Another limitation of our findings is that female animals did not have significant obesity although they gain weight with HFD challenge. It is possible that this is due to the use of the C57Bl/6J strain which is commonly used in obesity but does not have the same obesity induction in females as other strains such as DBA/2J and C3H/HeJ. However, these two strains do not have as robust of an inflammatory response. Future studies in multiple strains with both sexes are necessary to understand the generalizability of these results.
A unique aspect of our studies is the evaluation of tissue-specific leukocytes in both VSG and standard dietary WL. Clinical studies using RNASeq of adipose tissue have shown improved inflammatory markers after VSG , but a major limitation of these studies is that they were performed only in females. However, in these studies, there are some persistent inflammatory signals of interferon signaling pathways suggesting that some tissue remodeling continues post dietary weight loss  and VSG especially in those with higher insulin resistance [37, 38]. The ATM profile changes we see in our study hence have a similar phenotype to the clinical models of weight loss. A limitation to our study is that sometimes as obese men and women undertake lifestyle changes, they also increase physical activity. It is possible that if individuals were to further alter their lifestyle with diet and exercise, they may extend the improvement in inflammation compared to surgery or dietary-induced weight loss alone. Exercise independently reduces inflammation with more M2 macrophages and reduced total myeloid in adipose tissue  and liver . Further investigations into the effects of combined weight loss strategies are necessary to optimize the metabo-inflammatory responses to weight loss.
Overall, these results emphasize that sex differences in inflammatory responses to high-fat diet and weight loss make it critical to track prior weight history when counseling on metabolic and cardiovascular risk factors in the formerly obese individual. These results also suggest the importance of evaluating inflammation prior to and after weight loss interventions particularly in men. While we have not identified all the factors that need to be considered with weight loss intervention, we have shown that factors such as the method of weight loss, gender, and disease risks are important when caring for previously obese patients and when monitoring for any inflammation related conditions.
Adipose tissue macrophage
Glucose tolerance test
Gonadal white adipose tissue
Hematopoietic stem cells
Inguinal white adipose tissue
Visceral adipose tissue
Vertical sleeve gastrectomy
Finkelstein EA, Graham WC, Malhotra R. Lifetime direct medical costs of childhood obesity. Pediatrics. 2014;133(5):854–62.
Ogden CL, Carroll MD, Lawman HG, Fryar CD, Kruszon-Moran D, Kit BK, Flegal KM. Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013-2014. JAMA. 2016;315(21):2292–9.
Stokes A, Preston SH. Deaths attributable to diabetes in the United States: comparison of data sources and estimation approaches. PLoS One. 2017;12(1):e0170219.
Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, Ryan DH, Still CD, Endocrine S. Pharmacological management of obesity: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342–62.
Benoit SC, Hunter TD, Francis DM, De L, Cruz-Munoz N. Use of bariatric outcomes longitudinal database (BOLD) to study variability in patient success after bariatric surgery. Obes Surg. 2014;24(6):936–43.
Ryan DH, Kahan S. Guideline recommendations for obesity management. Med Clin North Am. 2018;102(1):49–63.
Westcott DJ, Delproposto JB, Geletka LM, Wang T, Singer K, Saltiel AR, Lumeng CN. MGL1 promotes adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesity. J Exp Med. 2009;206(13):3143–56.
Singer K, DelProposto J, Morris DL, Zamarron B, Mergian T, Maley N, Cho KW, Geletka L, Subbaiah P, Muir L, et al. Diet-induced obesity promotes myelopoiesis in hematopoietic stem cells. Mol Metab. 2014;3(6):664–75.
Boutens L, Stienstra R. Adipose tissue macrophages: going off track during obesity. Diabetologia. 2016;59(5):879–94.
Coats BR, Schoenfelt KQ, Barbosa-Lorenzi VC, Peris E, Cui C, Hoffman A, Zhou G, Fernandez S, Zhai L, Hall BA, et al. Metabolically activated adipose tissue macrophages perform detrimental and beneficial functions during diet-induced obesity. Cell Rep. 2017;20(13):3149–61.
Zamarron BF, Mergian TA, Cho KW, Martinez-Santibanez G, Luan D, Singer K, DelProposto JL, Geletka LM, Muir LA, Lumeng CN. Macrophage Proliferation Sustains Adipose Tissue Inflammation in Formerly Obese Mice. Diabetes. 2017;66(2):392–406. https://doi.org/10.2337/db16-0500. Epub 2016 Nov 8.
Frikke-Schmidt H, Zamarron BF, O'Rourke RW, Sandoval DA, Lumeng CN, Seeley RJ. Weight loss independent changes in adipose tissue macrophage and T cell populations after sleeve gastrectomy in mice. Mol Metab. 2017;6(4):317–26.
Cancello R, Zulian A, Gentilini D, Mencarelli M, Della Barba A, Maffei M, Vitti P, Invitti C, Liuzzi A, Di Blasio AM. Permanence of molecular features of obesity in subcutaneous adipose tissue of ex-obese subjects. Int J Obes. 2013;37(6):867–73.
Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294(15):1909–17.
Fuchs HF, Broderick RC, Harnsberger CR, Chang DC, Sandler BJ, Jacobsen GR, Horgan S. Benefits of bariatric surgery do not reach obese men. J Laparoendosc Adv Surg Tech A. 2015;25(3):196–201.
Williams RL, Wood LG, Collins CE, Callister R. Effectiveness of weight loss interventions--is there a difference between men and women: a systematic review. Obes Rev. 2015;16(2):171–86.
Selvin E, Paynter NP, Erlinger TP. The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med. 2007;167(1):31–9.
Kelly AS, Ryder JR, Marlatt KL, Rudser KD, Jenkins T, Inge TH. Changes in inflammation, oxidative stress and adipokines following bariatric surgery among adolescents with severe obesity. Int J Obes. 2016;40(2):275–80.
Jung DY, Ko HJ, Lichtman EI, Lee E, Lawton E, Ong H, Yu K, Azuma Y, Friedline RH, Lee KW, et al. Short-term weight loss attenuates local tissue inflammation and improves insulin sensitivity without affecting adipose inflammation in obese mice. Am J Physiol Endocrinol Metab. 2013;304(9):E964–76.
Hagman DK, Larson I, Kuzma JN, Cromer G, Makar K, Rubinow KB, Foster-Schubert KE, van Yserloo B, Billing PS, Landerholm RW, et al. The short-term and long-term effects of bariatric/metabolic surgery on subcutaneous adipose tissue inflammation in humans. Metabolism. 2017;70:12–22.
Wilson-Perez HE, Chambers AP, Ryan KK, Li B, Sandoval DA, Stoffers D, Drucker DJ, Perez-Tilve D, Seeley RJ. Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like peptide 1 receptor deficiency. Diabetes. 2013;62(7):2380–5.
Singer K, Morris DL, Oatmen KE, Wang T, DelProposto J, Mergian T, Cho KW, Lumeng CN. Neuropeptide Y is produced by adipose tissue macrophages and regulates obesity-induced inflammation. PLoS One. 2013;8(3):e57929.
Scheller EL, Khoury B, Moller KL, Wee NK, Khandaker S, Kozloff KM, Abrishami SH, Zamarron BF, Singer K. Changes in skeletal integrity and marrow adiposity during high-fat diet and after weight loss. Front Endocrinol (Lausanne). 2016;7:102.
Singer K, Maley N, Mergian T, DelProposto J, Cho KW, Zamarron BF, Martinez-Santibanez G, Geletka L, Muir L, Wachowiak P, et al. Differences in hematopoietic stem cells contribute to sexually dimorphic inflammatory responses to high fat diet-induced obesity. J Biol Chem. 2015;290(21):13250–62.
Stefater MA, Sandoval DA, Chambers AP, Wilson-Perez HE, Hofmann SM, Jandacek R, Tso P, Woods SC, Seeley RJ. Sleeve gastrectomy in rats improves postprandial lipid clearance by reducing intestinal triglyceride secretion. Gastroenterology. 2011;141(3):939–949 e931-934.
Christensen P, Meinert Larsen T, Westerterp-Plantenga M, Macdonald I, Martinez JA, Handjiev S, Poppitt S, Hansen S, Ritz C, Astrup A, et al. Men and women respond differently to rapid weight loss: metabolic outcomes of a multi-centre intervention study after a low-energy diet in 2500 overweight, individuals with pre-diabetes (PREVIEW). Diabetes Obes Metab. 2018;20:2840.
Kosteli A, Sugaru E, Haemmerle G, Martin JF, Lei J, Zechner R, Ferrante AW Jr. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest. 2010;120(10):3466–79.
Grayson BE, Gutierrez-Aguilar R, Sorrell JE, Matter EK, Adams MR, Howles P, Karns R, Seeley RJ, Sandoval DA. Bariatric surgery emphasizes biological sex differences in rodent hepatic lipid handling. Biol Sex Differ. 2017;8:4.
Flolo TN, Andersen JR, Kolotkin RL, Aasprang A, Natvig GK, Hufthammer KO, Vage V. Five-year outcomes after vertical sleeve gastrectomy for severe obesity: a prospective cohort study. Obes Surg. 2017;27(8):1944–51.
Kratz M, Hagman DK, Kuzma JN, Foster-Schubert KE, Chan CP, Stewart S, van Yserloo B, Westbrook EO, Arterburn DE, Flum DR, et al. Improvements in glycemic control after gastric bypass occur despite persistent adipose tissue inflammation. Obesity (Silver Spring). 2016;24(7):1438–45.
Young MT, Phelan MJ, Nguyen NT. A decade analysis of trends and outcomes of male vs female patients who underwent bariatric surgery. J Am Coll Surg. 2016;222(3):226–31.
Varghese M, Griffin C, McKernan K, Eter L, Lanzetta N, Agarwal D, Abrishami S, Singer K. Sex differences in inflammatory responses to adipose tissue lipolysis in diet-induced obesity. Endocrinology. 2018;160:293.
Griffin C, Eter L, Lanzetta N, Abrishami S, Varghese M, McKernan K, Muir L, Lane J, Lumeng CN, Singer K. TLR4, TRIF, and MyD88 are essential for myelopoiesis and CD11c(+) adipose tissue macrophage production in obese mice. J Biol Chem. 2018;293(23):8775–86.
Han J, Koh YJ, Moon HR, Ryoo HG, Cho CH, Kim I, Koh GY. Adipose tissue is an extramedullary reservoir for functional hematopoietic stem and progenitor cells. Blood. 2010;115(5):957–64.
Poitou C, Perret C, Mathieu F, Truong V, Blum Y, Durand H, Alili R, Chelghoum N, Pelloux V, Aron-Wisnewsky J, et al. Bariatric surgery induces disruption in inflammatory signaling pathways mediated by immune cells in adipose tissue: a RNA-Seq study. PLoS One. 2015;10(5):e0125718.
Fischer IP, Irmler M, Meyer CW, Sachs SJ, Neff F, Hrabe de Angelis M, Beckers J, Tschop MH, Hofmann SM, Ussar S. A history of obesity leaves an inflammatory fingerprint in liver and adipose tissue. Int J Obes. 2018;42(3):507–17.
Gonzalez-Plaza JJ, Santiago-Fernandez C, Gutierrez-Repiso C, Garcia-Serrano S, Rodriguez-Pacheco F, Ho-Plagaro A, Garrido-Sanchez L, Moreno-Ruiz FJ, Rodriguez-Canete A, Garcia-Fuentes E. The changes in the transcriptomic profiling of subcutaneous adipose tissue after bariatric surgery depend on the insulin resistance state. Surg Obes Relat Dis. 2018;14:1182.
Jahansouz C, Xu H, Hertzel AV, Kizy S, Steen KA, Foncea R, Serrot FJ, Kvalheim N, Luthra G, Ewing K, et al. Partitioning of adipose lipid metabolism by altered expression and function of PPAR isoforms after bariatric surgery. Int J Obes. 2018;42(2):139–46.
You T, Arsenis NC, Disanzo BL, Lamonte MJ. Effects of exercise training on chronic inflammation in obesity : current evidence and potential mechanisms. Sports Med. 2013;43(4):243–56.
Monteiro PA, Prado W, Dos Santos Tenorio TR, Tomaz LM, St-Pierre DH, Lira FS. Immunometabolic changes in hepatocytes arising from obesity and the practice of physical exercise. Curr Pharm Des. 2018;24:3200.
Dr. Carey Lumeng for his advice on study design and data analysis and interpretation.
This work was carried out with the support of the Pediatrics Charles Woodson Collaborative Research Award, NIH/NIDDK K08DK101755, R01DK115583, and Edith Briskin/SKS Foundation Taubman Emerging Scholar support to K.S. NIH/NIDDK R24DK092759 to O.M. and American Diabetes Association 1-18-PDF-087 to Z.L. This work was also supported in part by NIH Awards, DK082480 (DAS). CH was supported by T32 DK101357, a multidisciplinary training program in basic diabetes research. The investigators also received funding from Novo Nordisk A/S (DAS). This work utilized Core Services from the Michigan Nutrition and Obesity Research Center, supported by NIH grant DK089503 to the University of Michigan.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Ethics approval and consent to participate
All mouse procedures were approved by the University of Michigan Committee on Use and Care of Animals and were conducted in compliance with the Institute of Laboratory Animal Research Guide for the Care and Use of Laboratory Animals.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.